StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Lonza Group AG
Swiss Stock Exchange:LONN.SW
Sector
Location
Market Cap
USD 51.32 B
Share Price
USD 711.40
Avg Daily Volume
174,942
Change (1 day)
-0.10%
Change (1 year)
31.67%
Change (YTD)
20.07%
Lonza Group AG Market Capitalization on July 01, 2025: USD 51.32 B
Lonza Group AG Market Capitalization is USD 51.32 B on July 01, 2025, a 30.35% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Lonza Group AG 52-week low Market Capitalization is USD 52.32 B on July 01, 2025, which is 1.95% above the current Market Capitalization.
-
Lonza Group AG 52-week low Market Capitalization is USD 40.11 B on July 01, 2025, which is -21.84% below the current Market Capitalization.
-
Lonza Group AG average Market Capitalization for the last 52 weeks is USD 45.74 B.
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
UCB SA
USD 196.98
UCB.BR
+0.20
0.10%
Hansoh Pharmaceutical Group Company Limited
USD 3.82
3692.HK
+0.03
0.87%
Insmed Incorporated
USD 97.62
INSM
-3.02
-3.00%
Summit Therapeutics Inc.
USD 21.20
SMMT
-0.08
-0.38%
Torrent Pharmaceuticals Limited
USD 39.84
TORNTPHARM.NS
-0.07
-0.17%
Mankind Pharma Limited
USD 26.87
MANKIND.NS
+0.15
0.57%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
UCB SA
USD 196.98
UCB.BR
+0.20
0.10%
Hansoh Pharmaceutical Group Company Limited
USD 3.82
3692.HK
+0.03
0.87%
Insmed Incorporated
USD 97.62
INSM
-3.02
-3.00%
Summit Therapeutics Inc.
USD 21.20
SMMT
-0.08
-0.38%
Torrent Pharmaceuticals Limited
USD 39.84
TORNTPHARM.NS
-0.07
-0.17%
Mankind Pharma Limited
USD 26.87
MANKIND.NS
+0.15
0.57%